Shareholders Equity: The sum of preferred and common equity items.
Stoke Therapeutics, Inc. (STOK) had Shareholders Equity of $334.94M for the most recently reported fiscal quarter, ending 2025-06-30.
| Income Statement Financials | |
$13.82M |
|
$-23.48M |
|
-- |
|
$13.82M |
|
$41.12M |
|
$-27.30M |
|
$3.82M |
|
$-23.48M |
|
$-23.48M |
|
$-23.48M |
|
$-23.48M |
|
$-23.48M |
|
$-23.48M |
|
$-27.30M |
|
$-26.33M |
|
58.35M |
|
58.35M |
|
$-0.40 |
|
$-0.40 |
|
| Balance Sheet Financials | |
$269.97M |
|
$3.34M |
|
$114.54M |
|
$384.51M |
|
$38.68M |
|
-- |
|
$10.89M |
|
$49.56M |
|
$334.94M |
|
$334.94M |
|
|
Shareholders Equity |
$334.94M |
54.72M |
|
| Cash Flow Statement Financials | |
$106.41M |
|
$-134.84M |
|
$1.93M |
|
$128.78M |
|
$102.27M |
|
$-26.51M |
|
$14.35M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.98 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-197.58% |
|
-197.58% |
|
-- |
|
-169.96% |
|
-169.96% |
|
$106.10M |
|
-- |
|
-- |
|
-- |
|
0.04 |
|
-- |
|
8.52 |
|
10.57 |
|
-7.01% |
|
-7.01% |
|
-6.11% |
|
-7.01% |
|
$6.12 |
|
$1.82 |
|
$1.82 |
|